Article
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
5 Jul 2022
Abstract excerpt
BACKGROUND: Proficient Human Papillomavirus (HPV) genotyping services are essential to support HPV and cervical cancer elimination strategies, in particular to support HPV vaccine research. OBJECTIVES: To perform a global HPV genotyping proficiency study, with evaluation in relation to previous proficiency studies. STUDY DESIGN: The proficiency panel contained 44 coded samples (40 samples containing one or more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
